TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement September 30, 2020
Orchard Therapeutics Receives EMA PRIME Designation for OTL-203 for the Treatment of MPS-I September 28, 2020
Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors September 25, 2020
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma September 25, 2020
Whatfix for ISVs is Now Available, Helping Partners and Customers Accelerate Technology Adoption and Digital Transformation September 22, 2020
Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT™ (avapritinib) in Patients with Advanced Systemic Mastocytosis September 22, 2020